United Kingdom· GB-APID-3977011000001108

Cymevene 250mg capsules

A ganciclovir product containing ganciclovir, registered in United Kingdom by Roche Products Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC J05AB06

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ganciclovirAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ganciclovir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AB06 (ganciclovir), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
7 of them publish a price we can compare per daily dose

Search ganciclovir products by name

Ganciclovir · ATC J05AB06

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ganciclovir costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ganciclovir · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$494.50

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Ganciclovir
Manufacturer: Roche Products Ltd
Country: United Kingdom (GB)
ATC code: J05AB06
ATC class: Ganciclovir
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for ganciclovir.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ganciclovir against other medicines How interaction checks work

Ganciclovir · interactions on record

277 records

8 severe
194 moderate
75 info

Most severe, free to view

CladribineL01BB04severe
TrospiumA03AB20moderate
Amphotericin BA07AA07moderate
NitisinoneA16AX04moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ganciclovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Cymevene, Ganciclovir Oresund Pharma
Belgium · Cymevene, Virgan
Bulgaria · Ганцикловир Ромфарм
Czechia · Cymevene, Virgan
Germany · Cymeven I.V., Ganciclovir Accord
Denmark · Cymevene, Ganciclovir Oresund Pharma
Spain · Cymevene, Ganciclovir Accord
Finland · Cymevene, Ganciclovir Bioglan
France · Cymevan, Ganciclovir Hikma
Greece · Gancilen, Virgan
Croatia · Cymevene
Hungary · Cymevene, Ganciclovir Rompharm
Ireland · Cymevene
Italy · Citovirax, Ganciclovir Accord
Luxembourg · Cymevene, Virgan
Netherlands · Cymevene, Ganciclovir Sandoz
Norway · Cymevene, Ganciclovir Bioglan
Poland · Cymevene, Ganciclovir Accord
Portugal · Cymevene, Ganciclovir Accord
Romania · Ganciclovir Rompharm, Virgan
Sweden · Cymevene, Ganciclovir Bioglan
Slovakia · Cymevene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/64e0c903-d10d-440c-a8c2-1375320ace7e
GET /v1/drugs/64e0c903-d10d-440c-a8c2-1375320ace7e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3977011000001108",
  "desc": "Cymevene 250mg capsules (Roche Products Ltd)",
  "form": "Oral capsule",
  "vpid": "41486511000001101",
  "source": "dmd",
  "vtm_id": "776081008",
  "strength": "250 mg",
  "substance": "Ganciclovir",
  "ingredient": "Ganciclovir",
  "supplier_code": "2085201000001100"
}

API reference MCP server Plans

See everything about ganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console